| Friday, 3 September 2021 | ||
|---|---|---|
| 08:30-09:00 | Opening Session | |
| 08:30-09:00 | Welcome Speech | Dr. M. Derya Balbay |
| 09:00-10:00 | Session 1 Chairs: Dr. Ali İhsan Taşçı, Dr. Halil Çiftçi |
|
| 09:00-09:15 | Where are we at in screening with PSA? | Dr. Murat Bozlu |
| 09:15-09:30 | NIH Lecture: PI-RADS: past, present, future | Dr. Barış Türkbey |
| 09:30-09:45 | Natural History of biopsy negative PIRADS 4-5 index lesions in mpMRI | Dr. Tarık Esen |
| 09:45-10:00 | Discussion | |
| 10:00-10:40 | Session 2 Chairs: Dr. Eyüp Gümüş, Dr. Ercan Yeni |
|
| 10:00-10:15 | WUOF Lecture: Microultrasound as a competitor for MRI | Dr. Laurence Klotz |
| 10:15-10:30 | PSMA: The new centerforward in prostate cancer | Dr. Yasemin Şanlı |
| 10:30-10:40 | Discussion | |
| 10:40-11:40 | Session 3 Chairs: Dr. Jean de la Rosette, Dr. Öztuğ Adsan |
|
| 10:40-10:55 | Clinical application of 3D-Cancer map based on MRI-US fusion biopsy | Dr. Kazumi Kamoi |
| 10:55-11:10 | IPF Lecture: Transperineal prostate biopsy for MRI-indeterminant indications: what convinced me and what might convince you | Dr. John Davis |
| 11:10-11:25 | BAUS Lecture: Transperineal biopsy using grid and freehand using precision point device | Dr. Ben Challacombe |
| 11:25-11:40 | Discussion | |
| 11:40-11:55 | MIRRA BREAK | |
| 11:55-12:55 | Session 4 Chairs: Dr. İsmet Yavaşcaoğlu, Dr. Murat Dinçer |
|
| 11:55-12:10 | WUOF lecture: Use of biomarkers in selecting patients for active surveillance and focal ablation | Dr. Laurence Klotz |
| 12:10-12:25 | Prostate cancer: Prognostic and therapeutic tissue markers | Dr. Rodolfo Montironi |
| 12:25-12:40 | Germline mutations in metastatic prostate cancer: Influence on treatment selection | Dr. Timuçin Çil |
| 12:40-12:55 | Discussion | |
| 12:55-13:50 | LUNCH | |
| 13:50-14:35 | SATELLITE SYMPOSIA | |
| 14:35-15:35 | Session 5 Chairs: Dr. Ahmet Özet, Dr. Ziya Akbulut |
|
| 14:35-14:50 | Dietary modifications after prostate cancer diagnosis | Dr. Adem Deligönül |
| 14:50-15:05 | Integrative oncology in prostate cancer | Dr. Ömer Küçük |
| 15:05-15:20 | New approaches in non-surgical treatment of localized prostate cancer: HIFU, CRYO | Dr. Volkan Tuğcu |
| 15:20-15:35 | Discussion | |
| 15:35-16:55 | Session 6 Chairs: Dr. Mustafa Adlı, Dr. Nurettin Cem Sönmez |
|
| 15:35-15:50 | EAU Lecture: Adjuvant versus early salvage radiotherapy following radical prostatectomy | Dr. Derya Tilki |
| 15:50-16:05 | Current status of pelvic lymphadenectomy: To do or not to do | Dr. Asıf Yıldırım |
| 16:05-16:20 | Surgical and Radiation treatment in ‘de novo’ Metastatic Prostate Cancer | Dr. Brian Chapin |
| 16:20-16:35 | New horizons in prostate cancer radiotherapy | Dr. Hale Çağlar |
| 16:35-16:55 | Discussion | |
| 16:55-17:10 | MIRRA BREAK | |
| 17:10-18:30 | Session 7 Chairs: Dr. Atıf Akdaş, Dr. Türkkan Evrensel |
|
| 17:10-17:25 | Lu-177 and Ra-223 in the treatment algorithm: How does it stack up? | Dr. Meltem Çağlar |
| 17:25-17:40 | Immunotherapy in prostate cancer | Dr. Fatih Selçukbiricik |
| 17:40-17:55 | Therapeutic shift in hormone sensitive prostate cancer | Dr. Ömer Fatih Ölmez |
| 17:55-18:10 | Therapeutic options in non-metastatic castration-resistant prostate cancer | Dr. Amit Bahl |
| 18:10-18:30 | Discussion | |
| 18:30-19:00 | Session 8 Başkanı: Dr. Bülent Akduman |
|
| 18:30-19:00 | Case discussions -Prostate | Dr. Laurence Klotz Dr. Hale Çağlar Dr. Faysal Dane Dr. Serkan Güngör |
| 19:00-19:45 | SATELLITE SYMPOSIA | |
| Saturday, 4 September 2021 | ||
| 08:00-09:20 | Session 9 Chair: Dr. Halil Başar, Dr. Nagehan Barışık |
|
| 08:00-08:15 | Whats new in urinary cytology in the evaluation of urothelial cancer | Dr. Güliz Akdas Barkan |
| 08:15-08:30 | Urobiome and bladder cancer: a new era for research | Dr. Öner Şanlı |
| 08:30-08:45 | VI-RADS (Vesical imaging-Reporting and data system) | Dr. Valeria Panebianco |
| 08:45-09:00 | Histological variants in urothelial cancer | Dr. Berrak Gümüşkaya Öcal |
| 09:00-09:20 | Discussion | |
| 09:20-10:40 | Session 10 Chairs: Dr. Altuğ Tuncel, Dr. Erdem Göker |
|
| 09:20-09:35 | SIU Lecture: TURBT -from good to better to best | Dr. Jean de la Rosette |
| 09:35-09:50 | Does maximal TURBT improve outcomes prior to cystectomy or neoadjuvant chemotherapy? | Dr. Semih Ayan |
| 09:50-10:05 | Optimal and emerging treatments for NMIBC | Dr. Sam S. Chang |
| 10:05-10:20 | Pro/Con: Role of surgery in regional lymph node metastatic urothelial cancers | Dr. Orhan Koca |
| 10:20-10:40 | Discussion | |
| 10:40-10:55 | MIRRA BREAK | |
| 10:55-11:55 | Session 11 Chairs: Dr. Yaşar Özgök, Dr. Serkan Altınova |
|
| 10:55-11:10 | IRCC Lecture: Robotic cystectomy and urinary diversion | Dr. Khurshid Guru |
| 11:10-11:25 | IRCC Lecture: Future of surgery 2040 | Dr. Khurshid Guru |
| 11:25-11:40 | ESUT Lecture: New robotic platforms in urology and the initial uro-oncologic outcomes | Dr. Ali Serdar Gözen |
| 11:40-11:55 | Discussion | |
| 11:55-12:35 | Session 12 Chairs: Dr. Öner Odabaş, Dr. Ali Fuat Atmaca |
|
| 11:55-12:10 | ERUS Lecture: Innovation in robotic training | Dr. Alexandre Mottrie |
| 12:10-12:25 | Laparoscopic Radical Prostatectomy in the robotic era | Dr. Shin Egawa |
| 12:25-12:35 | Discussion | |
| 12:35-13:20 | SATELLITE SYMPOSIA | |
| 13:20-14:10 | LUNCH | |
| 14:10-15:10 | Session 13 Chairs: Dr. Mahmut Gümüş, Dr. Hale Çağlar |
|
| 14:10-14:25 | Shift of immunotherapy in bladder cancer: From metastatic disease to neoadjuvant setting | Dr. Enrique Grande |
| 14:25-14:40 | Anti-FGFR agents for bladder cancer | Dr. Mustafa Karaca |
| 14:40-14:55 | Options for patients not eligible for cystectomy | Dr. Yasemin Bölükbaşı |
| 14:55-15:10 | Discussion | |
| 15:10-15:50 | Session 14 Chairs: Dr. Özgür Özyılkan, Dr. Ramazan Gökhan Atış |
|
| 15:10-15:25 | ESOU lecture: New perspectives in the management of upper tract urothelial carcinoma | Dr. Morgan Roupret |
| 15:25-15:40 | Neoadjuvant vs. adjuvant chemotherapy for UTUC | Dr. Çağatay Arslan |
| 15:40-15:50 | Discussion | |
| 15:50-16:05 | MIRRA BREAK | |
| 16:05-16:35 | Session 15 Chair: Dr. Sakıp Erturhan |
|
| 16:05-16:35 | Case discussion: Optimizing management of high risk NMIBC | Dr. Mehmet Fatih Akbulut Dr. Serkan Altınova Dr. Mustafa Kemal Atilla Dr. Hasan Rıza Aydın |
| 16:35-17:05 | Session 16 Chair: Turhan Çaşkurlu |
|
| 16:35-17:05 | Case discussions: Optimizing management of MIBC/Locally Advanced Bladder Cancer | Dr. Rahim Horuz Dr. Ali Nahit Şendur Dr. Mustafa Cengiz Dr. Selçuk Erdem |
| 17:05-18:25 | Session 17 Chairs: Dr. Ahmet Yaser Müslümanoğlu, Dr. Şeref Kömürcü |
|
| 17:05-17:20 | Serum MicroRNA as a novel tumor marker for testicular germ cell tumor | Dr. Yılmaz Aslan |
| 17:20-17:35 | EAU Lecture: The Current Role of Retroperitoneal Lymph Node Dissection in Testicular Cancer | Dr. Pilar Laguna |
| 17:35-17:50 | Pro/Con: Minimally invasive RPLND | Dr. Mutlu Ateş |
| 17:50-18:05 | Whats new in the systemic treatment of testicular cancer | Dr. Nuri Karadurmuş |
| 18:05-18:25 | Discussion | |
| 18:25-19:10 | SATELLITE SYMPOSIA | |
| Sunday, 5 September 2021 | ||
| 08:00-09:20 | Session 18 Chairs: Dr. Özkan Polat, Dr. Bülent Orhan |
|
| 08:00-08:15 | RCC Familiar Syndromes and When to Screen | Dr. Pilar Laguna |
| 08:15-08:30 | Rare hereditary renal cell carcinomas: What the radiologist need to know? | Dr. Ashkan Malayeri |
| 08:30-08:45 | Radiologic evaluation of sub types in renal masses | Dr. Nesrin Gündüz |
| 08:45-09:00 | Emerging biomarkers and therapeutic targets for renal cell carcinoma | Dr. Mustafa Karaağaç |
| 09:00-09:20 | Discussion | |
| 09:20-10:00 | Session 19 Chairs: Dr. Sadık Görür, Dr. Abdurrahman Işıkdoğan |
|
| 09:20-09:35 | Surveillance for renal cell carcinoma: Is there a better way? | Dr. Cüneyt Özden |
| 09:35-09:50 | Overview of challenges in adjuvant RCC trials | Dr. Cemil Bilir |
| 09:50-10:00 | Discussion | |
| 10:00-10:30 | Session 20 Chair:Dr. Pilar Laguna |
|
| 10:00-10:30 | Interactive panel discussion: Integrating surgery and systemic therapy for locally advanced and metastatic RCC | Dr. Bülent Akduman Dr. Semih Ayan Dr. Özcan Yıldız |
| 10:30-11:00 | Session 21 Chair: Dr. Öner Şanlı |
|
| 10:30-11:00 | Case discussions -Kidney | Dr. Hasan Bakırtaş Dr. Selahattin Bedir Dr. Selçuk Şahin Dr. Taner Korkmaz |
| 11:00-11:15 | MIRRA BREAK | |
| 11:15-11:45 | Session 22 Chairs: Dr. Emin Özbek, Dr. Ali Arıcan |
|
| 11:15-11:45 | Panel: Introduction to Molecular biology for clinicians |
Dr. Dilek Telci Dr. Ahmet Bilici |
| 11:45-12:25 | Session 23 Chairs: Dr. Mustafa Güneş, Dr. Metin Özkan |
|
| 11:45-12:00 | Basic consepts in immuno-oncology | Dr. Ozan Yazıcı |
| 12:00-12:15 | Epigenetic regulation of OCT1 in castration resistant prostate cancer cells | Dr. Daisuke Obinata |
| 12:15-12:25 | Discussion | |
| 12:25-13:15 | LUNCH | |
| 13:15-14:25 | Session 24 Chairs: Dr. İlhan Geçit, Dr. Sedat Soyupek |
|
| 13:15-13:30 | NIH Lecture: Are physicians following the BPH guidelines? | Dr. Ziya Kırkali |
| 13:30-13:45 | Turkish validation of LURN | Dr. Meftun Çulpan |
| 13:45-13:55 | Alpha blockers | Dr. Ali Atan |
| 13:55-14:05 | 5ARI combination | Dr. Abdürrahim İmamoğlu |
| 14:05-14:15 | PDE5i combination | Dr. Halil Lütfi Canat |
| 14:15-14:25 | Discussion | |
| 14:25-14:55 | Session 25 Chairs: Dr. Mehmet Gülüm, Dr. Hakan Harputluoğlu |
|
| 14:25-14:55 | Take home messages | Dr. Bahri Gök Dr. Erdem Çubukçu |
| 14:55-15:10 | Closing Session | |
| 14:55-15:10 | Closing Remarks | Dr. Erdem Canda |
| Abstract Session-1 Chairs: Dr. Abdullah Demirtaş, Dr. Fikret Halis |
||
| Abstract Session-2 Chairs: Dr. Öner Odabaş, Dr. Mansur Halilov |
||
| Abstract Session-3 (Video Abstract Session) Chairs: Dr. Tevfik Aktöz, Dr. Murat Arslan |
||